Compound Detail

CHEMBL4177342

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

COc1cc(/C=C2\CN(S(=O)(=O)c3ccc(F)cc3)C/C(=C\c3cc(OC)cc(OC)c3)C2=O)cc(OC)c1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4177342
Phase	Preclinical
Structure Type	MOL
InChI Key	LEPNDEZVSSKZKO-VGENTYGXSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

553.6

MW (Da)

4.60

ALogP

HBA

HBD

91.4

PSA (Å²)

0.38

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 5.09

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HepG2 CHEMBL395	IC50	5.09	5.09	8100.0	1
SMMC-7721 CHEMBL613831	IC50	5.09	5.09	8210.0	1
QGY-7703 CHEMBL4296490	IC50	4.94	4.94	11440.0	1
Unchecked CHEMBL612545	IC50	4.84	4.84	14410.0	1
L02 CHEMBL4296457	IC50	4.7	4.7	19800.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HepG2	IC50	=	8100.0	nM	5.09	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability a...	29909338
SMMC-7721	IC50	=	8210.0	nM	5.09	Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viabilit...	29909338
QGY-7703	IC50	=	11440.0	nM	4.94	Cytotoxicity against human QGY7703 cells assessed as reduction in cell viability...	29909338
Unchecked	IC50	=	14410.0	nM	4.84	Cytotoxicity against human HHL5 cells assessed as reduction in cell viability af...	29909338
L02	IC50	=	19800.0	nM	4.7	Cytotoxicity against human LO2 cells assessed as reduction in cell viability aft...	29909338

PubMed	DOI	Target Context	# Activities
29909338	10.1016/j.ejmech.2018.06.027	HepG2	1
29909338	10.1016/j.ejmech.2018.06.027	QGY-7703	1
29909338	10.1016/j.ejmech.2018.06.027	SMMC-7721	1
29909338	10.1016/j.ejmech.2018.06.027	Unchecked	1
29909338	10.1016/j.ejmech.2018.06.027	L02	1
29909338	10.1016/j.ejmech.2018.06.027	RAW264.7	1

Data from ChEMBL 36 via Core Engine